Immunotherapy Using Histobulin in Atopic Dermatitis
Abstract
Immunotherapy using Histobulin was attempted in four cases of atopic
dermatitis. The patients improved considerably, and one patient showed
remission. The patients showed considerable improvement with a lower
frequency of upper respiratory infections during immunotherapy.20 May 2020Submitted to Clinical Case Reports 21 May 2020Submission Checks Completed
21 May 2020Assigned to Editor
04 Jun 2020Reviewer(s) Assigned
11 Jun 2020Review(s) Completed, Editorial Evaluation Pending
28 Jun 2020Editorial Decision: Revise Minor
19 Aug 20201st Revision Received
20 Aug 2020Submission Checks Completed
20 Aug 2020Assigned to Editor
20 Aug 2020Review(s) Completed, Editorial Evaluation Pending
20 Aug 2020Reviewer(s) Assigned
03 Sep 2020Editorial Decision: Revise Minor
04 Sep 20202nd Revision Received
05 Sep 2020Assigned to Editor
05 Sep 2020Submission Checks Completed
05 Sep 2020Review(s) Completed, Editorial Evaluation Pending
05 Sep 2020Reviewer(s) Assigned
12 Oct 2020Editorial Decision: Accept
Jan 2021Published in Clinical Case Reports volume 9 issue 1 on pages 113-117. 10.1002/ccr3.3472 
